help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Souza, C. D.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Souza, C. D.
Right arrow Articles by Orme, I. M.
Am. J. Respir. Cell Mol. Biol., Volume 23, Number 2, August 2000 188-193

A Novel Nonclassic beta 2-Microglobulin-Restricted Mechanism Influencing Early Lymphocyte Accumulation and Subsequent Resistance to Tuberculosis in the Lung

Celine D. D'Souza, Andrea M. Cooper, Anthony A. Frank, Stefan Ehlers, Joanne Turner, Albert Bendelac, and Ian M. Orme

Mycobacterial Research Laboratories, Departments of Microbiology and Pathology, Colorado State University, Fort Collins, Colorado; Division of Molecular Infection Biology, Research Center Borstel, Center for Medicine and Biosciences, Borstel, Germany; and Department of Molecular Biology, Princeton University, Princeton, New Jersey


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In this study, we compared the course of a low-dose aerosol Mycobacterium tuberculosis infection in mice bearing gene disruptions for the beta 2-microglobulin molecule, the CD8 molecule, and the CD1 molecule. Over the first 50 d of infection, the CD8- and CD1-disrupted mice were no more susceptible to infection than were the control mice. In contrast, the bacterial load in beta 2-microglobulin gene-disrupted mice increased rapidly and attained much higher levels than that observed in the other gene-disrupted mice and in control mice. A second major difference between the beta 2-microglobulin gene-disrupted mice and the other animals was the development of lung granulomas; both the CD8- and CD1-disrupted mice developed essentially normal granulomas except for an apparent increased lymphocyte influx in the CD8-disrupted mice. The beta 2-microglobulin gene-disrupted mice, on the other hand, developed granulomas virtually devoid of lymphocytes, with these cells instead localized within prominent perivascular cuffing adjacent to the lesions. These data support the hypothesis that a beta 2-microglobulin-dependent, non-CD8- and non-CD1-dependent mechanism controls the early and efficient influx of protective lymphocytes into infected lesions, and that the absence of this mechanism decreases the capacity of the animal to initially deal with pulmonary tuberculosis.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The successful expression of acquired protective immunity to tuberculosis infection involves the intimate interaction between infected macrophages and effector (protective) T cells. It is clear from many studies that T cells, and more specifically CD4 T cells, mediate the bulk of the protective and anamnestic host responses (1). These cells clonally expand in the presence of interleukin (IL)-2 and respond to the macrophage cytokine IL-12 by producing large quantities of inteferon (IFN)-gamma (7). In humans, a reduction in CD4 T cells or an inability to mediate signals via the IL-12/IFN-gamma pathway renders the individual highly susceptible to mycobacterial infection (10).

There is, however, evidence to support a role for other T cells in pulmonary infection. CD8 T cells harvested from immune mice transferred prolonged survival in an acute aerosol infection model (3), and naive CD8 T cells protected athymic mice against intravenous infection (11). In addition, work by Flynn and colleagues (12) clearly demonstrated a substantially increased susceptibility of beta 2-microglobulin gene-disrupted (beta 2-m-KO) mice to intravenous infection with virulent Mycobacterium tuberculosis. These mice had increased growth of the bacilli within lung tissue and exhibited substantial necrosis and tissue damage in that organ.

Owing to the inability of the beta 2-m-KO mice to sensitize CD8 T cells, it was reasonable to conclude at that time that the increased susceptibility was due to the lack of this subset of T cells. To confirm this, we compared beta 2-m-KO and CD8 gene-disrupted (KO) mice in a relevant low-dose infection model. Surprisingly, our data failed to confirm this hypothesis. Although CD8-KO mice allow increased bacterial growth in the lung late in infection, the loss of resistance in the beta 2-m-KO mice occurs much earlier and is more severe. This loss of resistance in the beta 2-m-KO mice appears to be associated with a failure to adequately recruit lymphocytes, but not macrophages, to sites of bacterial infection in the lungs.

As a result of these findings, we hypothesized that other molecules associated with beta 2-microglobulin may play a role in moderating the development of pulmonary granulomas. To test this hypothesis, we infected CD1 gene-disrupted mice in the same manner as the beta 2-m-KO and CD8-KO mice. These mice lack the beta 2-microglobulin-associated nonpolymorphic major histocompatibility complex (MHC) class 1-like molecule that serves to sensitize natural killer (NK) 1.1-positive, alpha beta T cells (13). These NK T cells have been shown to release several cytokines and chemokines very rapidly upon activation and have been suggested to play a role in initiating and/or modulating the acquired immune response (14). We show here, however, that these mice exhibited no increased susceptibility to M. tuberculosis infection nor did they show any evidence of altered granuloma formation. We therefore hypothesize that a previously unrecognized, non-CD8, non-CD1, beta 2-microglobulin-dependent mechanism is operative early in infected lungs and serves to control the efficient accumulation of lymphocytes into this tissue.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Mice and Infections

beta 2-m-KO mice on both the B6/129 background and the C57BL/6 background were purchased from Jackson Laboratories (Bar Harbor, ME). Littermate control mice, C57BL/6 mice, and founder CD8-KO mice were also purchased from Jackson Laboratories. CD8-KO mice were bred in the Painter Center animal facility at Colorado State University (Fort Collins, CO) and were consistently negative for CD8-positive cells by flow cytometry. CD1-KO mice were generated and tested as described (13), bred at Princeton University animal facility (Princeton, NJ) and transferred to Colorado State for infection. The CD1 gene disruption was backcrossed onto the C57BL/6 background six times. Mice were housed in the BL3 facility and given mouse chow and water ad libitum.

A virulent strain of M. tuberculosis (Erdman) was grown from a low-passage-number seed lot in Proskauer-Beck liquid medium to mid-log phase, aliquoted, and frozen at -70°C. Mice were infected using a Glas-Col aerosol generator (Glas-Col, Terre Haute, IN) such that 100 bacteria were deposited in the lungs of each animal (8). The numbers of viable bacteria in target organs were determined at various time points by plating serial dilutions of partial organ homogenates on nutrient Middlebrook 7H11 agar and counting colonies after 20 d of incubation at 37° C. A Day 1 count was performed to determine the infecting dose.

Some mice were treated with a blocking anti-CD1 antibody (rat immunoglobulin [Ig] G1 clone 20H2, 1 mg/mouse intraperitoneally) (15) at Days -1, +1, 3, and 5 of an aerosol infection. Control mice received rat IgG1 isotype control antibody following the same regimen.

Histologic Analysis

The lower right lobe of each mouse was inflated with 10% neutral-buffered saline and processed routinely for light microscopy. Sections were then stained with hematoxylin and eosin. Slides were examined without knowledge of experimental group and subjectively graded for both quantity and quality of cellular accumulation. Repeat evaluations were performed to confirm that grading was reproducible.

In addition, sections from formalin-fixed tissue were deparaffinated and placed in 10 mM sodium citrate buffer (pH 6), followed by pressure cooking for exactly 1 min. After blocking for 20 min in 1% H2O2 solution, slides were incubated with appropriately diluted polyclonal rabbit antimouse nitric oxide synthase (NOS)2 (Genzyme-Virotech, Russelsheim, Germany) in Tris-buffered saline/10% fetal calf serum for 30 min in a humid chamber. As bridging antibody, appropriately diluted goat-antirabbit-IgG-peroxidase (Dianova, Hamburg, Germany) and as tertiary antibody, diluted rabbit-antigoat-IgG-peroxidase (Dianova) was used in sequential incubations of 30 min each. Development was performed with diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO) and urea superoxide (Sigma), and hemalum was used to counterstain the slides. Isotype-matched antibody was used on some sections to confirm that staining was specific (data not shown).

Isolation of Messenger RNA and Detection of Cytokine-Specific Message by Reverse Transcriptase/Polymerase Chain Reaction

Infected and control tissues were excised, placed in Ultraspec (Cinna/Biotecx, Friendswood, TX), homogenized, and RNA was extracted as described previously (7). One microgram of total RNA was reverse-transcribed, diluted and underwent polymerase chain reaction (PCR) expansion of cytokine-specific complementary DNA (cDNA). The amount of cytokine-related product was determined by the exposure of blotted cDNA PCR product to fluorescein-tagged cytokine sequence-specific probe. The enhanced chemiluminescence kit (Amersham, Arlington Heights, IL) was used to detect the presence of fluorescein by horseradish peroxidase-conjugated antibody. The resultant light signal was detected using Hyperfilm (Amersham). The number of cycles that generate a log-linear relationship between the signal on film and the dilution of the sample was determined empirically (7). Data are expressed as the "fold increase" in signal for experimental points relative to the control value from uninfected lung tissue. The significance of the fold increase over uninfected tissue was determined by an unpaired Student's t test comparing the means of the signals from uninfected versus infected tissue.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Increased Bacterial Growth in beta 2-Microglobulin Null Mice after Infection via the Aerogenic Route

Figure 1 represents data from two independent experiments. In each case, gene-disrupted and control animals were exposed to an aerosol infection that resulted in the deposition of about 100 bacteria into the lungs. Both C57BL/6 and B6/129 mouse data were pooled, as they did not differ from each other. CD8-KO mice were not significantly more susceptible to the aerogenic infection up to Day 55 but did show increased bacterial growth at later time points starting from Day 75 (data not shown).


View larger version (59K):
[in this window]
[in a new window]
 
Figure 1.   Mice lacking beta 2-microglobulin are more susceptible to aerogenic infection than are mice lacking CD8. Mice were exposed to an aerogenic infection with virulent M. tuberculosis such that each mouse received roughly 100 bacteria in the lung. Lungs were harvested from the mice at several time points and plated to determine the number of colony-forming units per lung. Data from 16 control C57BL/6 and B6/129 mice were pooled (solid bars), as there was no significant difference between the mean values of these two groups (Student's t test, P > 0.05). The mean values for eight mice per time point are shown for both the CD8-KO (striped bars) and the beta 2-m-KO (gray bars) mice. A statistically significant difference was observed between the beta 2-m-KO mice and the control and CD8-KO mice (asterisks) (Student's t test, P < 0.05).

In the beta 2-m-KO mice, the bacterial numbers increased more rapidly than in either the control mice or the CD8-KO mice. The difference was significant by Day 30 (P < 0.05). After that time, although the infection was apparently contained and did not result in the death of any animals, bacterial loads remained elevated through Day 90.

Because these data implied that the early loss of resistance in beta 2-m-KO mice was not due to a lack of the CD8 molecule, we then assessed the effect of disrupting only the CD1 molecule on murine resistance to an aerogenic mycobacterial infection. Figure 2 shows the pooled data from two independent experiments using C57BL/6 mice, heterozygote (CD1+/-) mice, and homozygote CD1-/- mice. There was no difference in bacterial growth either very early (Day 7) or during the control phase of infection (Day 23 or Day 44) in the lungs or spleens of the CD1-KO mice. In addition, mice treated with a blocking antibody to CD1 did not exhibit any increased susceptibility during the early stages of infection (Table 1).


View larger version (40K):
[in this window]
[in a new window]
 
Figure 2.   Mice lacking CD1d1 are not more sensitive to aerogenic infection than are control mice. Mice were infected and lungs harvested as in Figure 1. There was no statistically significant difference between the mean colony-forming unit values for control C57BL/6 mice (solid bars), heterozygote mice (striped bars), or the CD1-KO mice (gray bars) (Student's t test, P > 0.05) over the course of the experiment. The data shown are a representative result from two separate experiments.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Treatment with anti-CD1 antibody during aerogenic infection with Mycobacterium tuberculosis does not increase susceptibility to disease

Histologic Analysis of Lung Tissues after Aerosol Infection

The histologic appearance of lung tissues was followed over the course of infection. In control mice, mild interstitial pneumonia was observed at 15 d, which was followed after 20 to 30 d by the gradual emergence of the granulomatous response. This response was characterized by the presence of organized rafts of lymphocytes within fields of epithelioid macrophages (Figures 3A and 3B). The response was similar in the CD8-KO mice, with the exception that as the infection progressed more lymphocytes were seen within the granuloma, and large perivascular lymphocytic cuffs were seen around adjacent blood vessels (Figure 3C). In addition, CD1-KO mice developed a granulomatous response in the lungs in a similar manner to control mice (data not shown).


View larger version (153K):
[in this window]
[in a new window]
 
Figure 3.   Few lymphocytes are observed in the early granulomas of the beta 2-m-KO mice. Representative fields from the lungs of C57BL/6 (A), B6/129 (B), CD8-KO (C), and beta 2-m-KO mice (D) 55 d after infection. Mice were infected as in Figure 1, and samples for histology were taken at each time point. Note the florid lymphocyte accumulations in A, B, and C (arrowheads) and the predominance of macrophages and absence of lymphocytes in plate D. Hematoxylin and eosin staining was used.

Examination of beta 2-m-KO mice early in infection revealed a similar development of mild interstitial pneumonia, followed gradually by the accumulation of large numbers of epithelioid macrophages. Few lymphocytes were observed, predominantly in the perivascular region (Figure 3D). As the infection progressed, the perivascular cuffing grew more prominent but at no time was there any evidence of lymphocyte influx beyond the spaces adjacent to the blood vessels and into the epithelioid macrophage field (Figures 4A, 4B, and 4C). Furthermore, from about Day 30 onwards, these macrophage fields contained substantially increased numbers of degenerative "foamy" macro-phages (Figure 4C) with concordant necrosis. Probably secondary to this necrosis, more neutrophils were observed in these sections. Interestingly, the ability of the epithelioid macrophages to express the inducible NOS (iNOS) gene product was unimpaired in the granulomas of beta 2-m-KO mice, as determined by immunohistochemistry (Figure 5).


View larger version (99K):
[in this window]
[in a new window]
 
Figure 4.   As disease progresses, perivascular cuffing of lymphocytes becomes prominent in the lungs of the beta 2-m-KO mice. Lung sections from beta 2-m-KO mice at 30 (A), 55 (B), and 90 d (C) after aerosol infection. The paucity of lymphocytes within the granuloma is clear, as is increasingly evident cuffing of lymphocytes (black arrowheads) around the blood vessels (white arrows). Hematoxylin and eosin staining.


View larger version (148K):
[in this window]
[in a new window]
 
Figure 5.   Both control and beta 2-m-KO mice express iNOS within the lung granulomas. Formalin-fixed tissue samples were processed for immunohistochemical analysis as described. The images represent lung sections from beta 2-m-KO (A) and control mice (B) at Day 55 of infection. The dark brown stain indicates the presence of immunoreactive iNOS protein. Expression of this enzyme is focused in the macrophage accumulations in both groups of mice.

Expression of Both Messenger RNA for IFN-gamma in Infected Lungs and Secretion of IFN-gamma by Antigen-Specific Cells

To determine whether the increased susceptibility of the beta 2-m-KO mice was a result of ineffective induction of IFN-gamma , the levels of cytokine-specific messenger RNA (mRNA) in the lungs of each mouse were determined. In two separate experiments, the kinetics and magnitude of IFN-gamma mRNA expression were not statistically different between the control mice and either the beta 2-m-KO mice or the CD8-KO mice. The relative fold increase in signal for both Day 30 and Day 55 infected lungs is shown in Table 2.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Increase in IFN-gamma mRNA in lungs infected aerogenically with Mycobacterium tuberculosis

Changes in mRNA levels for the chemokine monocyte chemotactic protein (MCP)-1 was also measured and a moderate, but significant, early increase in mRNA signal for this macrophage chemokine (Figure 6) was detected in the lungs of the beta 2-m-KO mice as compared with either the control or CD8-KO mice.


View larger version (20K):
[in this window]
[in a new window]
 
Figure 6.   beta 2-m-KO mice exhibit earlier and enhanced expression of mRNA for the chemokine MCP-1 in response to infection. Lung samples were taken from each of the control mice (closed circles), beta 2-m-KO mice (open triangles), and CD8-KO mice (closed squares), and RNA was extracted. The mean fold increase over Day 0 pixel values for MCP-1 is shown at three time points (n = 4). The statistical significance of the increase in mean experimental pixel values over the mean Day 0 pixel values for both MCP-1 was determined by Student's t test (*P < 0.05). The statistical significance of the differences between the mean fold increase in control and gene-disrupted mice at each time point was also determined using the Student's t test (dagger P < 0.05). Equivalent amounts of cDNA from each mouse were compared as determined by the signal obtained for the housekeeping gene hypoxanthine guanine phosphoribosyl transferase.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The results of this study show that beta 2-m-KO mice are more susceptible than control mice to a low-dose aerosol infection with M. tuberculosis. In addition, the data provided evidence that the underlying mechanism resulting in this susceptibility was related not to an inability to generate protective immunity per se but seemed to be associated instead with an apparent inability to focus lymphocytes within infected lesions in the lung. Subsequent experiments revealed that this deficiency was not related to loss of CD8 or CD1 molecules, despite the association of beta 2-microglobulin with these molecules.

The evidence supporting this hypothesis was the striking difference in the histologic appearance of the lungs harvested during the early phase of infection. The CD8-KO, CD1-KO, and control mice all exhibited the expected granulomatous response (16) with the only difference being a possible increase in lymphocyte infiltration seen in CD8-KO mice. In stark contrast, however, the beta 2-m-KO mouse lungs showed a progressive macrophage influx in the virtual absence of any lymphocytes. As this response proceeded, lymphocytes did accumulate but they remained in gradually expanding perivascular cuffs and failed to infiltrate the macrophage-dominated lesion. Within these lesions, many of the macrophages had a histiocytic or vacuolated appearance, some had become multinucleated giant cells, and many appeared to be degenerative.

Intriguingly, despite the reduced ability of the beta 2-m-KO mice to control the early growth of the infection, IFN-gamma mRNA was expressed in the lung with the same kinetics as seen in the control mice. In addition, this IFN-gamma was able to mediate expression of iNOS in the epithelioid macrophages of both the control and beta 2-m-KO pulmonary granulomas. To explain this, it is reasonable to speculate that the lymphocytes accumulating close to the arterioles adjacent to the macrophage granulomas were the source of this cytokine.

Several lines of evidence, including the data reported here, allow us to develop the hypothesis that there are two phases of the immune response in the lungs after tuberculosis infection. A very early, presumably innate response appears to require beta 2-microglobulin but is independent of the CD8 molecule. In its absence, the bacterial load in the lungs rapidly increases, and the histologic appearance of the lungs is dramatically altered. Because our data seemed to exclude CD8, we then pursued the idea that the consequences of beta 2-microglobulin disruption were operative via the CD1 molecule. This molecule requires beta 2-microglobulin to be expressed (17), is able to bind unusual hydrophobic motifs (18), and is able to stimulate NK T cells (19). This natural T-cell subset occurs in both mice and humans, and responds rapidly to stimulation by the release of cytokines; as a result, it is thought to represent a bridge between the innate response and the acquired response (14). That our hypothesis was incorrect, however, was shown by experiments in which mice lacking the CD1d1 molecule (the only CD1 molecule expressed by C57BL/6 mice [20]) were able to control early infection in a manner similar to that of control mice. Moreover, the histologic appearance of the lungs during the infection did not differ from those of the control animals.

Our data indicate that presentation of mycobacterial antigens by CD1 molecules to NK T cells does not appear to play a role in early immune responses to tuberculosis in the murine lung. This is consistent with a recent report by Behar and colleagues (21), which showed that even when given a large intravenous dose of M. tuberculosis, CD1-KO mice were not more susceptible than control mice. There are, however, several other mechanisms that may be involved in the very early innate response during pulmonary infection. For example, there are several other nonclassic MHC class 1-related molecules that require beta 2-microglobulin for expression and that are associated with recognition of bacterial products or altered self (22). Whereas the evidence presented here indicates that CD8-dependent cells are not involved in the early resistance mechanism, there are other cell populations, such as gamma delta T cells, that could potentially recognize nonpolymorphic class 1-like molecules.

While there is increasing evidence that nonpolymorphic, beta 2-microglobulin-dependent MHC-like molecules may provide an early warning of bacterial invasion or tissue damage (22), it remains completely unknown how this is achieved. Our working hypothesis is that bacterial antigens (probably easily detachable lipoglycans or lipoproteins from the outer surface of the cell envelope) are presented to an as yet undefined (presumably) T-cell subset. This presentation then leads to the development of local changes that result in the influx of mononuclear cells (23). This is probably a complex event, involving increased permeability of the local capillary bed, expression of adhesion/integrin molecules, and the production of chemokines that will preferentially attract lymphocytes and monocytes rather than neutrophils (24).

In the current study, we observed an increased expression of the chemokine MCP-1 in the beta 2-m-KO mice, in association with the increased bacterial load and florid macrophage influx. That this macrophage influx is not matched by an equally strong lymphocyte accumulation suggests that there may be a deficiency in the more T cell- directed chemoattractants. This might help to explain the capacity of accumulating lymphocytes to adhere to and cross the local arteriolar vessels but then fail to move through the intracellular matrix and into the developing granulomas. This inability of lymphocytes to move into the granuloma would also explain the results of Flynn and colleagues (25) who found that the beta 2-m-KO mice were not protected in the lungs by Calmette-Guerin bacillus vaccination, suggesting that circulating T cells could not properly focus in the lungs.

Finally, although the efficient formation of the granuloma is not intrinsically protective (26), it is needed to help contain the infection and prevent dissemination and/or subsequent regrowth (27). Models, such as the one presented here, may help to explain how the host response recognizes the presence of a formidable intracellular bacterial infection with the need to induce the formation of a granuloma. This recognition then leads to the formation of a structure consisting of lymphocytes and macrophages rather than a more destructive neutrophil-dominated influx. The evidence to date suggests that the local inflammation and beta  chemokines stimulate the macrophage influx (23, 28) and that a controlling element is gamma delta T cells (29), possibly triggered by mycobacterial fragments (30). The current study may have uncovered a previously unrecognized, even earlier-acting mechanism, mediated by the presentation of mycobacterial products by a beta 2-microglobulin-dependent molecule, that is responsible for the efficient recruitment of lymphocytes directly into the granuloma.

    Footnotes

Address correspondence to: Andrea Cooper, Department of Microbiology, Colorado State University, 200 West Lake, Fort Collins, CO 80523. E-mail: acooper{at}cvmbs.colostate.edu

(Received in original form December 14, 1999 and in revised form March 7, 2000).

Abbreviations: beta 2-microglobulin gene-disrupted, beta 2-m-KO; complementary DNA, cDNA; CD1 gene-disrupted, CD1-KO; CD8 gene-disrupted, CD8-KO; immunoglobulin, Ig; interferon, IFN; interleukin, IL; induced nitric oxide synthase, iNOS; major histocompatibility complex, MHC; messenger RNA, mRNA; monocyte chemotactic protein, MCP; natural killer, NK; polymerase chain reaction, PCR.

Acknowledgments: This work was supported by NIH-NIAID grants AI-40488 and AI-44072.
    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Lefford, M. J.. 1975. Transfer of adoptive immunity to tuberculosis in mice. Infect. Immun. 11: 1174-1181 [Abstract/Free Full Text].

2. Orme, I. M., and F. M. Collins. 1983. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy: requirement for T cell-deficient recipients. J. Exp. Med. 158: 74-83 [Abstract/Free Full Text].

3. Orme, I. M.. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138: 293-295 [Abstract].

4. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148: 189-196 [Abstract].

5. Orme, I. M.. 1988. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J. Immunol. 140: 3589-3593 [Abstract].

6. Andersen, P., A. Andersen, A. Sorenson, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154: 3359-3372 [Abstract].

7. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432 [Medline].

8. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178: 2243-2247 [Abstract/Free Full Text].

9. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254 [Abstract/Free Full Text].

10. Bellamy, R., and A. V. S. Hill. 1998. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr. Opin. Immunol. 10: 483-487 [Medline].

11. Tascon, R. E., E. Stavropoulos, K. V. Lukacs, and M. J. Colston. 1998. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect. Immun. 66: 830-834 [Abstract/Free Full Text].

12. Flynn, J., M. Goldstein, K. Triebold, and B. Bloom. 1993. Major histocompatibility complex class I-restricted T cells are necessary for protection against Mycobacterium tuberculosis in mice. Infectious Agents and Disease 2: 259-262 [Medline].

13. Park, S.-H., D. Guy-Grand, F. A. Lemonnier, C.-R. Wang, A. Bendelac, and B. Jabri. 1999. Selection and expansion of CD8alpha alpha +TCRalpha beta + intestinal intraepithelial lymphocyte in the absence of both classical MHC class I and non-classical CD1 molecules. J. Exp. Med. 190: 885-890 [Abstract/Free Full Text].

14. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific autoreactive T cells: development, specificity and function. Annu. Rev. Immunol. 15: 535-550 [Medline].

15. Roark, J. H., S.-H. Park, J. Jayawarendena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160: 3121-3127 [Abstract/Free Full Text].

16. Rhoades, E. R, A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78: 57-66 [Medline].

17. Brutkiewicz, R. R., J. R. Bennink, J. W. Yewdell, and A. Bendelac. 1995. TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182: 1913-1919 [Abstract/Free Full Text].

18. Zeng, Z. H., A. R. Castano, B. Segelke, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1997. The crystal structure of murine CD1: an MHC-like fold with a large hydrophobic antigen-binding groove. Science 277: 339-341 [Abstract/Free Full Text].

19. Bendelac, A., O. Lantz, M. E. Quimby, J. W. Yewdell, J. R. Bennick, and R. R. Brutkiewicz. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863-868 [Abstract/Free Full Text].

20. Park, S.-H., J. H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160: 3128-3134 [Abstract/Free Full Text].

21. Behar, S. M., C. C. Dascher, M. J. Grusby, C.-R. Wang, and M. B. Brenner. 1999. Susceptibility of mice deficient in CD1d or TAP-1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189: 1973-1980 [Abstract/Free Full Text].

22. Kronenberg, M., L. Brossay, Z. Kurepa, and J. Forman. 1999. Conserved lipid and peptide presentation functions of nonclassical class I molecules. Immunol. Today 20: 515-521 [Medline].

23. Orme, I. M.. 1998. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6: 94-97 [Medline].

24. Orme, I. M., and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 20: 307-312 [Medline].

25. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89: 12013-12017 [Abstract/Free Full Text].

26. Johnson, C. M., A. M. Cooper, A. A. Frank, and I. M. Orme. 1998. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect. Immun. 66: 1666-1670 [Abstract/Free Full Text].

27. Saunders, B. M., A. A. Frank, and I. M. Orme. 1999. Granuloma formation is required to contain bacterial growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98: 324-328 [Medline].

28. Rhoades, E. R., A. M. Cooper, and I. M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63: 3871-3877 [Abstract].

29. D'Souza, C. D., A. M. Cooper, A. A. Frank, R. J. Mazzaccaro, B. R. Bloom, and I. M. Orme. 1997. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158: 1217-1221 [Abstract].

30. Constant, P., F. Davodeau, M. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. Fournie. 1994. Stimulation of human gamma delta T cells by non-peptidic mycobacterial ligands. Science 264: 267-269 [Abstract/Free Full Text].

31. Schoel, B., S. Sprenger, and S. H. E. Kaufmann. 1994. Phosphate is essential for stimulation of Vgamma 9Vdelta 2 T lymphocytes by mycobacterial low molecular weight ligands. Eur. J. Immunol. 24: 1886-1892 [Medline].

32. Tanaka, Y., C. Morita, Y. Tanaka, E. Nieves, M. Brenner, and B. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375: 155-158 [Medline].

33. Pfeffer, K., B. Schoel, H. Gulle, S. H. E. Kaufman, and H. Wagner. 1990. Primary responses of human T cells to mycobacteria: a frequent set of gamma /delta T cells are stimulated by protease-resistant ligands. Eur. J. Immunol. 20: 1175-1179 [Medline].





This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. L. Cogen and T. A. Moore
{beta}2-Microglobulin-Dependent Bacterial Clearance and Survival during Murine Klebsiella pneumoniae Bacteremia
Infect. Immun., January 1, 2009; 77(1): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
B. Sherry, W. W. Dai, M. L. Lesser, and H. Trachtman
Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 397 - 406.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
J. Exp. Med., December 19, 2005; 202(12): 1715 - 1724.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Gonzalez-Juarrero, J. M. Hattle, A. Izzo, A. P. Junqueira-Kipnis, T. S. Shim, B. C. Trapnell, A. M. Cooper, and I. M. Orme
Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection
J. Leukoc. Biol., June 1, 2005; 77(6): 914 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Junqueira-Kipnis, A. Kipnis, A. Jamieson, M. G. Juarrero, A. Diefenbach, D. H. Raulet, J. Turner, and I. M. Orme
NK Cells Respond to Pulmonary Infection with Mycobacterium tuberculosis, but Play a Minimal Role in Protection
J. Immunol., December 1, 2003; 171(11): 6039 - 6045.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Skold and S. M. Behar
Role of CD1d-Restricted NKT Cells in Microbial Immunity
Infect. Immun., October 1, 2003; 71(10): 5447 - 5455.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
O. C. Turner, R. G. Keefe, I. Sugawara, H. Yamada, and I. M. Orme
SWR Mice Are Highly Susceptible to Pulmonary Infection with Mycobacterium tuberculosis
Infect. Immun., September 1, 2003; 71(9): 5266 - 5272.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Dieli, M. Taniguchi, M. Kronenberg, S. Sidobre, J. Ivanyi, L. Fattorini, E. Iona, G. Orefici, G. De Leo, D. Russo, et al.
An Anti-Inflammatory Role for V{alpha}14 NK T cells in Mycobacterium bovis Bacillus Calmette-Guerin-Infected Mice
J. Immunol., August 15, 2003; 171(4): 1961 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. B. Urdahl, D. Liggitt, and M. J. Bevan
CD8+ T Cells Accumulate in the Lungs of Mycobacterium tuberculosis-Infected Kb-/-Db-/- Mice, But Provide Minimal Protection
J. Immunol., February 15, 2003; 170(4): 1987 - 1994.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. E. Schaible, H. L. Collins, F. Priem, and S. H.E. Kaufmann
Correction of the Iron Overload Defect in {beta}-2-Microglobulin Knockout Mice by Lactoferrin Abolishes Their Increased Susceptibility to Tuberculosis
J. Exp. Med., December 2, 2002; 196(11): 1507 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Chackerian, J. Alt, V. Perera, and S. M. Behar
Activation of NKT Cells Protects Mice from Tuberculosis
Infect. Immun., November 1, 2002; 70(11): 6302 - 6309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Lazarevic and J. Flynn
CD8+ T Cells in Tuberculosis
Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1116 - 1121.
[Full Text] [PDF]


Home page
MicrobiologyHome page
V. Gruppo, O. C. Turner, I. M. Orme, and J. Turner
Reduced up-regulation of memory and adhesion/integrin molecules in susceptible mice and poor expression of immunity to pulmonary tuberculosis
Microbiology, October 1, 2002; 148(10): 2959 - 2966.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Turner, A. A. Frank, and I. M. Orme
Old Mice Express a Transient Early Resistance to Pulmonary Tuberculosis That Is Mediated by CD8 T Cells
Infect. Immun., August 1, 2002; 70(8): 4628 - 4637.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. M. Orme
The search for new vaccines against tuberculosis
J. Leukoc. Biol., July 1, 2001; 70(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S.-H. Park, A. Weiss, K. Benlagha, T. Kyin, L. Teyton, and A. Bendelac
The Mouse CD1d-restricted Repertoire Is Dominated by a Few Autoreactive T Cell Receptor Families
J. Exp. Med., April 9, 2001; 193(8): 893 - 904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Turner, C. D. D'Souza, J. E. Pearl, P. Marietta, M. Noel, A. A. Frank, R. Appelberg, I. M. Orme, and A. M. Cooper
CD8- and CD95/95L-Dependent Mechanisms of Resistance in Mice with Chronic Pulmonary Tuberculosis
Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 203 - 209.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
A. M. Cooper, J. E. Pearl, J. V. Brooks, S. Ehlers, and I. M. Orme
Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung
Infect. Immun., December 1, 2000; 68(12): 6879 - 6882.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Souza, C. D.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Souza, C. D.
Right arrow Articles by Orme, I. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.